Biosimilars Product Market Poised $19.4 Billion by 2014
According to a new market research report, ‘Global biosimilars Market (2009 - 2014)’, published by MarketsandMarkets, the global biosimilars market is expected to be worth US$19.4 billion by 2014, recording a CAGR of 89.1% from 2009 to 2014. The increasing demand from patients, insurers, and government agencies to reduce the costs of blockbuster biopharmaceuticals has created numerous opportunities in the global biosimilars market.
View full press release